Fig. 3From: The role of anti-citrullinated protein antibody reactivities in an inception cohort of patients with rheumatoid arthritis receiving treat-to-target therapyProportion of patients with radiographic progression by number of baseline ACPA reactivities after 12 months (n = 199) and 24 months (n = 195)Back to article page